Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 113, Issue 23, 5979-5998, June 4, 2009
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Changes in gene expression of granulocytes during in vivo granulocyte colony-stimulating factor/dexamethasone mobilization for transfusion purposes
Blood Drewniak et al. 113: 5979

Supplemental materials for: Drewniak et al

Files in this Data Supplement:

  • Table S1 (PDF, 42.3 KB) -
    Genes, which expression was similarly affected after in vivo and in vitro treatment with G-CSF- dexamethasone, were analyzed by the OntoExpress program (http://vortex.cs.wayne.edu/projects.htm#Onto-Express), and categorized into proper functional profiles (e.g. transcription, signal transduction, immune response, cell faith & apoptosis, cell adhesion & mobility, metabolism). Only selection of genes falls into those categories. Results are presented as the mean fold-increase or –decrease of three separate donors (comparison is with freshly isolated neutrophils t=0).

  • Table S2. Gene sequence data (XLS, 170 KB)

  • Figure S1. Scheme of the experiment (JPG, 76.4 KB) -





  • Figure S2. Regulation of calpastatin levels in neutrophils (JPG, 177 KB) -
    (A) Samples of neutrophils cultured in the presence or absence of G-CSF and dexamethasone were taken at the indicated times and analyzed by Western blot. Where indicated, CHX (10 µg/mL) was added to prevent new protein synthesis. Shown is a representative blot from 1 out of 5 independent experiments. (B) Samples of neutrophils cultured in the presence or absence of Calpain Inhibitor-3 (CI3, 20 µM) or the pan-caspase inhibitor zVAD (20 µM) were taken at the indicated time points and analyzed by Western blot. Shown is a representative blot from 1out of 5 independent experiments.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020